Beren Therapeutics raises $300 million for rare disease drug launch prep
Go back to Beren Therapeutics raises $300 million for rare disease drug launch prep| HERCULES TECHNOLOGY GROWTH CAPITAL, Inc. (NYSE: HTGC) | Delayed: 17.63 -0.09 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.72 | 52 Week High | $14.00 | |||
| Open | $17.75 | 52 Week Low | $9.92 | |||
| Day High | $17.80 | P/E | 10.02 | |||
| Day Low | $17.45 | EPS | $1.76 | |||
| Volume | 1,027,104 | |||||
